As well as early-phase trials, we conduct later-phase research across a range of disease areas, which may include complex treatment regimes or complicated translational components. All our clinical research teams have access to this facility.

The trial activity we cover includes trial set-up and monitoring, patient recruitment, patient assessment, treatment administration, sampling for pharmacokinetics and pharmacodynamincs, biomarkers, pre-analytic sample processing and storage of samples. The unit also has an outpatient area, phlebotomy area, day-care treatment area and a pre-analytic processing laboratory.



Manchester University Manchester Academic Health Science CentreCancer Research UK National Institute for Health Records